CELZ vs. ZIVO, EVAX, AIM, APTO, PMCB, SNTI, TVGN, IKT, COEP, and ONVO
Should you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include ZIVO Bioscience (ZIVO), Evaxion Biotech A/S (EVAX), AIM ImmunoTech (AIM), Aptose Biosciences (APTO), PharmaCyte Biotech (PMCB), Senti Biosciences (SNTI), Tevogen Bio (TVGN), Inhibikase Therapeutics (IKT), Coeptis Therapeutics (COEP), and Organovo (ONVO). These companies are all part of the "biological products, except diagnostic" industry.
ZIVO Bioscience (NASDAQ:ZIVO) and Creative Medical Technology (NASDAQ:CELZ) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.
ZIVO Bioscience has a beta of 0.26, meaning that its stock price is 74% less volatile than the S&P 500. Comparatively, Creative Medical Technology has a beta of 2.22, meaning that its stock price is 122% more volatile than the S&P 500.
12.8% of ZIVO Bioscience shares are held by institutional investors. Comparatively, 1.4% of Creative Medical Technology shares are held by institutional investors. 21.5% of ZIVO Bioscience shares are held by company insiders. Comparatively, 3.3% of Creative Medical Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
In the previous week, Creative Medical Technology had 3 more articles in the media than ZIVO Bioscience. MarketBeat recorded 3 mentions for Creative Medical Technology and 0 mentions for ZIVO Bioscience. ZIVO Bioscience's average media sentiment score of 1.46 beat Creative Medical Technology's score of 0.00 indicating that Creative Medical Technology is being referred to more favorably in the news media.
ZIVO Bioscience received 28 more outperform votes than Creative Medical Technology when rated by MarketBeat users. However, 68.93% of users gave Creative Medical Technology an outperform vote while only 61.11% of users gave ZIVO Bioscience an outperform vote.
Creative Medical Technology has lower revenue, but higher earnings than ZIVO Bioscience. ZIVO Bioscience is trading at a lower price-to-earnings ratio than Creative Medical Technology, indicating that it is currently the more affordable of the two stocks.
Creative Medical Technology has a net margin of 0.00% compared to Creative Medical Technology's net margin of -11,068.75%. Creative Medical Technology's return on equity of 0.00% beat ZIVO Bioscience's return on equity.
Summary
Creative Medical Technology beats ZIVO Bioscience on 9 of the 15 factors compared between the two stocks.
Get Creative Medical Technology News Delivered to You Automatically
Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CELZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Creative Medical Technology Competitors List
Related Companies and Tools
